#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anal cancer Leiomyosarcoma Thrombocytosis Haemolytic uraemic syndrome Immune thrombocytopenia Cutaneous T-cell lymphoma recurrent Adrenoleukodystrophy Keratosis follicular Metachromatic leukodystrophy Cutaneous lupus erythematosus Muscular dystrophy Hepatic angiosarcoma Infantile apnoea Waldenstrom's macroglobulinaemia recurrent Hyperchylomicronaemia More trials…

    Learn about Rare Diseases

    Synovial sarcoma – Basic Information Vascular malformation – Trials in Disease Glycogen storage disease type II – Treatment Mucopolysaccharidosis – Diagnostics Focal segmental glomerulosclerosis – Diagnostics Hairy cell leukaemia – Treatment Undifferentiated sarcoma – Treatment Richter’s syndrome – Treatment Mucopolysaccharidosis I – Trials in Disease Factor IX deficiency – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Buclizine Hydrochloride Gskvx000000017033 Nido-361 Tumor Necrosis Factor-Alpha Specific Nucleic Acid Sna-Veru Ganaxolone Cldn6 Car-T RP3 Azd3427 CHLORMADINONE ACETATE Metyrapone Mirtazapine Dc-806 Ivabradine Irinotecan Dexmedetomidine Hydrochloride VX-407 177LU-PSMA-I&T Nitrofurantoin 18F-Fludarabine More therapies…

    Learn about Your Condition

    Rhinitis allergic Infection Drug use disorder Supranuclear palsy Persistent depressive disorder Glomerulonephritis chronic Malignant melanoma stage IV Polymyalgia rheumatica Myasthenia gravis Pneumonia chlamydial Cerebrovascular accident Friedreich's ataxia Cortisol abnormal Cerebellar ataxia Oesophagectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Jean Perrin

Centre Jean Perrin

58 Rue Montalembert, Clermont Ferrand, 63000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Erdafitinib and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for Cisplatin Treatment

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Cetrelimab
    • Erdafitinib
    France Italy Spain

  • Study Comparing Sentinel Node Policy with Current Staging Protocols in Early Stage Endometrial Cancer Using Patent Blue, Technetium (99mTc) Rheniumsulfide, and Indocyanine Green

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Human Albumin Solution
    • Indocyanine Green
    France

  • Study on Zoledronic Acid for Treating Osteosarcoma in Children, Adolescents, and Adults

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Zoledronic Acid Monohydrate
    France

  • Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer recurrent
    • Breast cancer female
    • Breast cancer male
    Investigated Drugs:
    • Sacituzumab Govitecan
    • Capecitabine
    • Carboplatin
    Austria Belgium France Germany Ireland Spain

  • Study of Cabozantinib and Atezolizumab Compared to Hormonal Therapy in Adults with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Atezolizumab
    • Cabozantinib
    Belgium Czechia France Germany Greece Italy +3

  • Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Everolimus
    • Placebo
    Belgium France

  • Study Comparing Avelumab, Cetuximab, and Radiotherapy with Standard Treatments for Patients with Advanced Head and Neck Squamous Cell Carcinoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Avelumab
    • Cetuximab
    • Cisplatin
    France

  • Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    Investigated Drugs:
    • Cyclophosphamide
    • Docetaxel
    • Doxorubicin
    Belgium France

  • Study on the Effects of Atezolizumab, Trastuzumab, and Pertuzumab in Patients with Early-Stage Triple-Negative or HER2+ Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    • Triple negative breast cancer
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Pertuzumab
    France

  • Study Comparing Chemotherapy and Abemaciclib with Hormone Therapy for Patients with ER+ HER2- Metastatic Breast Cancer with Visceral Involvement

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated Drugs:
    • Abemaciclib
    • Anastrozole
    • Capecitabine
    France
Previous Page
1 … 11 12 13 14 15 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!